Haematology patients' desire to access metropolitan hospital expertise
Author(s)
McGrath, Pamela
Griffith University Author(s)
Year published
2016
Metadata
Show full item recordAbstract
Objective. To date, there is limited research to inform an understanding of cancer patients’ choice as to location
of treatment. This paper makes a contribution by providing findings on a group of regional, rural and remote cancer
patients, namely those diagnosed with a haematological malignancy, who have to relocate for specialist care in Queensland,
Australia.
Methods. A descriptive qualitative method was used based on 45 in-depth interviews with haematology patients living
in Queensland who were supported by the Leukaemia Foundation of Queensland.
Results. Four key factors were found to affect the decision making of ...
View more >Objective. To date, there is limited research to inform an understanding of cancer patients’ choice as to location of treatment. This paper makes a contribution by providing findings on a group of regional, rural and remote cancer patients, namely those diagnosed with a haematological malignancy, who have to relocate for specialist care in Queensland, Australia. Methods. A descriptive qualitative method was used based on 45 in-depth interviews with haematology patients living in Queensland who were supported by the Leukaemia Foundation of Queensland. Results. Four key factors were found to affect the decision making of patients who prefer to travel to metropolitan hospitals for specialist haematology treatments, namely access to own doctor, bonds and familiarity with metropolitan staff, desire for ‘quality’ specialist care and a distrust of local clinical care and, for some, the absence of usual barriers to visiting the metropolitan area. Conclusions. There are a group of patients who have experiences that lead them to distrust non-metropolitan hospitals and motivate them to travel long distances to attend specialist treating centres for ‘quality’ care. The literature affirms the concerns of this group. It is the hope and expectation in publishing this article that these patients’ concerns will be taken into consideration in the development of health services and policy so that eventually all regional, rural and remote patients will be provided with equitable choice with regard to the location of accessing specialist care.
View less >
View more >Objective. To date, there is limited research to inform an understanding of cancer patients’ choice as to location of treatment. This paper makes a contribution by providing findings on a group of regional, rural and remote cancer patients, namely those diagnosed with a haematological malignancy, who have to relocate for specialist care in Queensland, Australia. Methods. A descriptive qualitative method was used based on 45 in-depth interviews with haematology patients living in Queensland who were supported by the Leukaemia Foundation of Queensland. Results. Four key factors were found to affect the decision making of patients who prefer to travel to metropolitan hospitals for specialist haematology treatments, namely access to own doctor, bonds and familiarity with metropolitan staff, desire for ‘quality’ specialist care and a distrust of local clinical care and, for some, the absence of usual barriers to visiting the metropolitan area. Conclusions. There are a group of patients who have experiences that lead them to distrust non-metropolitan hospitals and motivate them to travel long distances to attend specialist treating centres for ‘quality’ care. The literature affirms the concerns of this group. It is the hope and expectation in publishing this article that these patients’ concerns will be taken into consideration in the development of health services and policy so that eventually all regional, rural and remote patients will be provided with equitable choice with regard to the location of accessing specialist care.
View less >
Journal Title
Australian Health Review
Volume
40
Issue
3
Subject
Public Health and Health Services not elsewhere classified